Gastroretentive Drug Delivery Systems Outsourcing Market Analysis and Forecast to 2033:By Technology (Floating Systems, Bioadhesive Systems, Expandable Systems), Dosage Form (Tablets/Capsules, Liquids, Pellets/Particles), End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)), and Region

Gastroretentive drug delivery systems (GRDDS) outsourcing is an emerging and innovative approach to drug delivery, which aims to improve the effectiveness of drugs by increasing their residence time in the stomach. This is accomplished by using delivery systems that are able to remain in the stomach for an extended period of time, thus allowing for more prolonged drug release. GRDDS outsourcing involves contracting out the development and/or production of these delivery systems to an external manufacturer.

GRDDS outsourcing can provide a number of advantages to pharmaceutical companies. By outsourcing the development and/or production of these delivery systems, companies can benefit from the expertise of the external manufacturer, thus reducing the time and cost associated with the development process. Additionally, GRDDS outsourcing allows companies to access the latest technologies and materials, thus allowing them to produce delivery systems with improved performance characteristics.

Key Trends

Gastroretentive drug delivery systems (GRDDS) are a type of drug delivery system that is designed to remain in the stomach for an extended period of time. They are used to deliver drugs such as proton pump inhibitors, antibiotics, anti-inflammatory drugs, and anti-ulcer drugs. This type of system is beneficial in the long run because it allows for sustained and controlled drug delivery over a long period of time, which can lead to improved efficacy and patient compliance.

In recent years, there has been a growing trend in outsourcing GRDDS technology. This is because, with advanced technology, it is now possible to develop and manufacture GRDDS with a high degree of precision and accuracy. By outsourcing the development and manufacturing of GRDDS, companies can save time and money, as well as benefit from the expertise of the provider.

One of the key trends in GRDDS outsourcing technology is the use of advanced 3D printing technology. 3D printing is a process of creating three-dimensional objects from a digital file. This technology can be used to produce GRDDS with a high degree of accuracy and precision. It allows for the creation of complex shapes and geometries that can be tailored to the needs of the drug. This can be used to create GRDDS that are designed to remain in the stomach for an extended period of time.

Another trend in GRDDS outsourcing technology is the use of advanced materials. Companies are now able to use a variety of materials, such as polymers, ceramics, and metals, to create GRDDS with improved performance. These materials can be used to create GRDDS that are designed to remain in the stomach for an extended period of time and are resistant to degradation. This allows for improved drug delivery and increased patient compliance.

Key Drivers

Gastroretentive Drug Delivery Systems Outsourcing is a rapidly growing market, driven by a number of factors. These factors include technological advancements, an increased demand for novel drug delivery systems, and an increasing focus on patient-centric drug delivery systems.

The first key driver of Gastroretentive Drug Delivery Systems Outsourcing is technological advancements. The development of novel drug delivery systems has enabled the development of more efficient and cost-effective drug delivery systems. For example, the use of nanotechnology in drug delivery systems has enabled the development of targeted drug delivery systems that deliver drugs directly to the site of action. This has resulted in improved patient outcomes and reduced side effects. Additionally, the use of 3D printing technology has enabled the development of complex drug delivery systems that have the potential to improve patient adherence and compliance.

The second key driver is the increased demand for novel drug delivery systems. As the global population ages, the need for improved drug delivery systems is becoming increasingly important. In particular, the development of gastroretentive drug delivery systems has enabled the delivery of drugs to the stomach, where they are better absorbed and have a longer duration of action. This has enabled patients to receive more effective treatment, resulting in improved patient outcomes and reduced side effects.

The third key driver is an increasing focus on patient-centric drug delivery systems. As the healthcare industry moves towards more patient-centric models, there is an increased need for drug delivery systems that are tailored to the individual patient’s needs. This has resulted in an increased demand for gastroretentive drug delivery systems, as they are better able to meet the needs of patients with chronic conditions.

Restraints & Challenges

Gastroretentive drug delivery systems (GRDDS) are a special class of drug delivery systems that are designed to remain in the stomach for a prolonged period of time in order to improve drug absorption and reduce side effects. Although GRDDS has been gaining increasing attention in recent years, there are several key restraints and challenges that are limiting the growth of the GRDDS outsourcing market.

Firstly, the development of GRDDS is an extremely complex process, requiring expertise in multiple disciplines such as pharmaceutical formulation, drug delivery, and manufacturing. This complexity makes it difficult for companies to find experienced and knowledgeable partners to outsource GRDDS development to. Additionally, there is a lack of standardized protocols for GRDDS development, which further complicates the process.

Secondly, the cost associated with GRDDS development is high, making it difficult for companies to justify the cost of outsourcing the process. Additionally, the long timelines associated with GRDDS development and the associated regulatory hurdles are also a major deterrent for companies looking to outsource the process.

Thirdly, the regulatory environment surrounding GRDDS is still evolving, and there is currently a lack of clarity surrounding the approval process for GRDDS. This uncertainty makes it difficult for companies to plan for the regulatory approval of their GRDDS, and makes it difficult to predict the timeline and cost associated with the process.

Market Segments

The global  Gastroretentive Drug Delivery Systems Outsourcing Market is segmented by technology, dosage form, end-user,  and region. By technology, the market is divided into floating systems, bioadhesive systems, expandable systems. Based on dosage form, it is bifurcated into tablets/capsules, liquids, pellets/particles. On the basis of end-user, the market is classified into pharmaceutical companies, biotechnology companies, contract research organizations (CROs), contract manufacturing organizations (CMOs). Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The global  Gastroretentive Drug Delivery Systems Outsourcing Market report includes players like Almac Group(US, Ireland, UK), Ajinomoto Pharmaceutical Co., Ltd.(Japan), Catalent (US, UK, France, Italy), Capsugel (US, France, Brazil), CordenPharma (Switzerland, Germany, Italy), Evonik Industries (Germany, US, China), Jubilant DraxImage LLC (US, India), Pharmalucence Inc. (Canada), Samsung Biologics (South Korea), Siegfried Holding AG (Switzerland)

 Gastroretentive Drug Delivery Systems Outsourcing Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current  Gastroretentive Drug Delivery Systems Outsourcing Market outlook and estimations from 2023 to 2033, which helps to recognize the prevalent opportunities.
  • The report also covers qualitative as well as quantitative analysis of  Gastroretentive Drug Delivery Systems Outsourcing Market in terms of revenue ($Million).
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the  Gastroretentive Drug Delivery Systems Outsourcing Market .
  • A thorough analysis of market trends and restraints is provided.
  • By region as well as country market analysis is also presented in this report.
  • Analytical depiction of the  Gastroretentive Drug Delivery Systems Outsourcing Market along with the current trends and future estimations to depict imminent investment pockets. The overall  Gastroretentive Drug Delivery Systems Outsourcing Market opportunity is examined by understanding profitable trends to gain a stronger foothold.
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the  Gastroretentive Drug Delivery Systems Outsourcing Market are also analyzed.

Why GIS?

 

Table of Contents

Chapter 1. Gastroretentive Drug Delivery Systems Outsourcing Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Years & Currency Considered in the Study
1.5. Research Methodologies
1.5.1. Secondary Research
1.5.1.1. Data Collection
1.5.1.2. List of Secondary Sources
1.5.1.3. Key Data from Secondary Sources
1.5.2. Primary Research
1.5.2.1. List of Primary Research Sources
1.5.3. Market Flavor Estimation: Top-Down Approach
1.5.4. Market Flavor Estimation: Bottom-Up Approach
1.5.5. Data Triangulation and Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
2.3. Analyst’s Review

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Technology
3.3. Market Attractiveness Analysis, by Dosage Form
3.4. Market Attractiveness Analysis, by End-User

Chapter 4. Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
4.1. Gastroretentive Drug Delivery Systems Outsourcing Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Material Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Gastroretentive Drug Delivery Systems Outsourcing Market
4.7. Impact of the Russia and Ukraine War on the Gastroretentive Drug Delivery Systems Outsourcing Market
4.8. Case Study Analysis
4.9. Pricing Analysis

Chapter 5. Gastroretentive Drug Delivery Systems Outsourcing Market , by Technology
5.1. Market Overview
5.2. Floating Systems
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region
5.3. Bioadhesive Systems
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region
5.4. Expandable Systems
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region

Chapter 6. Gastroretentive Drug Delivery Systems Outsourcing Market , by Dosage Form
6.1. Market Overview
6.2. Tablets/Capsules
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Liquids
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Pellets/Particles
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region

Chapter 7. Gastroretentive Drug Delivery Systems Outsourcing Market , by End-User
7.1. Market Overview
7.2. Pharmaceutical Companies
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. Biotechnology Companies
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Contract Research Organizations (CROs)
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Contract Manufacturing Organizations (CMOs)
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region

Chapter 8. Gastroretentive Drug Delivery Systems Outsourcing Market , by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.2.3. North America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.2.4. North America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.2.5. North America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Country
8.2.6. The U.S.
8.2.6.1. The U.S. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.2.6.2. The U.S. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.2.6.3. The U.S. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.2.7. Canada
8.2.7.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.2.7.2. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.2.7.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.2.8. Mexico
8.2.8.1. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.2.8.2. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.2.8.3. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.3. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.4. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.5. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Country
8.3.6. The U.K.
8.3.6.1. The U.K. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.6.2. The U.K. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.6.3. The U.K. Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.7. Germany
8.3.7.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.7.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.7.3. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.8. France
8.3.8.1. France Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.8.2. France Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.8.3. France Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.9. Spain
8.3.9.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.9.2. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.9.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.10. Italy
8.3.10.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.10.2. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.10.3. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.11. Netherlands
8.3.11.1. Netherlands Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.11.2. Netherlands Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.11.3. Netherlands Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.12. Sweden
8.3.12.1. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.12.2. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.12.3. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.13. Switzerland
8.3.13.1. Switzerland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.13.2. Switzerland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.13.3. Switzerland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.14. Denmark
8.3.14.1. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.14.2. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.14.3. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.15. Finland
8.3.15.1. Finland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.15.2. Finland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.15.3. Finland Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.16. Russia
8.3.16.1. Russia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.16.2. Russia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.16.3. Russia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.3.17.2. Rest of Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.3.17.3. Rest of Europe Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Country
8.4.3. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.4. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.5. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.6. China
8.4.6.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.6.2. China Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.6.3. China Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.7. India
8.4.7.1. India Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.7.2. India Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.7.3. India Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.8. Japan
8.4.8.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.8.2. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.8.3. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.9. South Korea
8.4.9.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.9.2. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.9.3. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.10. Australia
8.4.10.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.10.2. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.10.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.11. Singapore
8.4.11.1. Singapore Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.11.2. Singapore Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.11.3. Singapore Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.12. Indonesia
8.4.12.1. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.12.2. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.12.3. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.13. Taiwan
8.4.13.1. Taiwan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.13.2. Taiwan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.13.3. Taiwan Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.14. Malaysia
8.4.14.1. Malaysia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.14.2. Malaysia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.14.3. Malaysia Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.4.15. Rest of APAC
8.4.15.1. Rest of APAC Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.4.15.2. Rest of APAC Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.4.15.3. Rest of APAC Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.5. Rest of The World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of The World Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.5.3. Rest of The World Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.5.4. Rest of The World Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.5.5. Rest of The World Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Country
8.5.6. Latin America
8.5.6.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.5.6.2. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.5.6.3. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.5.7. Middle East
8.5.7.1. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.5.7.2. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.5.7.3. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form
8.5.8. Africa
8.5.8.1. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Technology
8.5.8.2. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by End-User
8.5.8.3. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Size and Forecast, by Dosage Form

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Competitive Leadership Mapping
9.3.1. Star Players
9.3.2. Innovators
9.3.3. Emerging Players
9.4. Vendor Benchmarking
9.5. Developmental Strategy Benchmarking
9.5.1. New Product Developments
9.5.2. Product Launches
9.5.3. Business Expansions
9.5.4. Partnerships, Joint Ventures, and Collaborations
9.5.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Almac Group(US, Ireland, UK)
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Ajinomoto Pharmaceutical Co., Ltd.(Japan)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Catalent (US, UK, France, Italy)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Capsugel (US, France, Brazil)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. CordenPharma (Switzerland, Germany, Italy)
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Evonik Industries (Germany, US, China)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Jubilant DraxImage LLC (US, India)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Pharmalucence Inc. (Canada)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Samsung Biologics (South Korea)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Siegfried Holding AG (Switzerland)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The List of Company Is Subject To Change During The Final Compilation of The Report
Market Segments

By Technology

  • Floating Systems
  • Bioadhesive Systems
  • Expandable Systems

By Dosage Form

  • Tablets/Capsules
  • Liquids
  • Pellets/Particles

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Spain
    • Italy
    • Netherlands
    • Sweden
    • Switzerland
    • Denmark
    • Finland
    • Russia
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Indonesia
    • Taiwan
    • Malaysia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

 

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Ultrasound devices emit high-frequency sound waves that are…
Optical Coherence Tomography (OCT) is a non-invasive imaging…
The global hearing aids market was valued at…
The liquid biopsy market was valued at USD…
The global Medical Gloves Market was valued at…
Ophthalmic equipment is equipment used to diagnose and…
The global HLA Typing for Transplant Market was…
The Medical Health Screening Services Market size was…
The global Extracorporeal Membrane Oxygenation Market was valued…
The intraoperative radiation therapy market was valued at…